Exagen Inc. Appoints Chas McKhann to Board of Directors
Provided By GlobeNewswire
Last update: Jul 17, 2025
CARLSBAD, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing solutions, announced today the appointment of Chas McKhann to its Board of Directors, effective July 17, 2025.
Read more at globenewswire.com9.38
+0.18 (+1.96%)
Find more stocks in the Stock Screener
XGN Latest News and Analysis
